Compounds > 4-nitroquinoline-1-oxide
Page last updated: 2024-08-17

4-nitroquinoline-1-oxide and methotrexate

4-nitroquinoline-1-oxide has been researched along with methotrexate in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's0 (0.00)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M1
Fahrig, R; Steinkamp-Zucht, A1
Kasamatsu, T; Kawazoe, Y; Kohda, K1
Brôco, N; Sá-Correia, I; Tenreiro, S; Viegas, CA1
Aardema, MJ; Clare, KR; Doherty, A; Fellows, MD; McDermott, A1
Abbasi, MM; Hamishehkar, H; Jahanban- Esfahlan, R; Monfaredan, A; Seidi, K1
Abbasi, MM; Hamishehkar, H; Jahanban-Esfahlan, R; Khiavi, MM; Monfaredan, A; Seidi, K1
Abbasi, MM; Abdal, K; Abdollahi, B; Aghbali, AA; Fotohi, S; Hamishehkar, H; Khiavi, MM; Salehi, R; Sina, M1

Other Studies

8 other study(ies) available for 4-nitroquinoline-1-oxide and methotrexate

ArticleYear
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:11

    Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity

2010
Monitoring of induced chromosomal aberrations in S. cerevisiae in agarose gels by pulsed field gel electrophoresis.
    Mutation research, 1995, Volume: 335, Issue:3

    Topics: 4-Nitroquinoline-1-oxide; Chromosome Aberrations; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Methotrexate; Mutagens; Saccharomyces cerevisiae; Thioguanine

1995
Comparison of chemically induced DNA breakage in cellular and subcellular systems using the comet assay.
    Mutation research, 1996, Jul-10, Volume: 369, Issue:1-2

    Topics: 4-Nitroquinoline-1-oxide; Animals; Antimetabolites, Antineoplastic; Bleomycin; DNA; DNA Damage; Fluorouracil; Hydrogen Peroxide; Leukemia L1210; Methotrexate; Methylnitrosourea; Mice; Mutagenicity Tests; Mutagens; Subcellular Fractions; Tumor Cells, Cultured

1996
FLR1 gene (ORF YBR008c) is required for benomyl and methotrexate resistance in Saccharomyces cerevisiae and its benomyl-induced expression is dependent on pdr3 transcriptional regulator.
    Yeast (Chichester, England), 1999, Volume: 15, Issue:15

    Topics: 4-Nitroquinoline-1-oxide; Antifungal Agents; Antimetabolites, Antineoplastic; Benomyl; Carcinogens; Carrier Proteins; Cycloheximide; DNA Primers; DNA-Binding Proteins; DNA, Fungal; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Fluconazole; Fungicides, Industrial; Gene Expression Regulation, Fungal; Membrane Transport Proteins; Methotrexate; Mutagenesis, Insertional; Organic Anion Transporters; Plasmids; Polymerase Chain Reaction; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Transcription Factors

1999
The spectral karyotype of L5178Y TK⁺/⁻ mouse lymphoma cells clone 3.7.2C and factors affecting mutant frequency at the thymidine kinase (tk) locus in the microtitre mouse lymphoma assay.
    Environmental and molecular mutagenesis, 2014, Volume: 55, Issue:1

    Topics: 4-Nitroquinoline-1-oxide; Animals; Culture Techniques; Horses; Hot Temperature; Karyotype; Lymphoma; Methotrexate; Mice; Mutagenicity Tests; Mutation Rate; Serum; Thymidine Kinase; Time Factors; Tumor Cells, Cultured

2014
Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:15

    Topics: 4-Nitroquinoline-1-oxide; Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinogens; Carcinoma, Squamous Cell; Down-Regulation; Doxorubicin; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Mouth Neoplasms; Nanoparticles; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor C

2014
Oral and IV dosages of doxorubicin-methotrexate loaded- nanoparticles inhibit progression of oral cancer by down- regulation of matrix Methaloproteinase 2 expression in vivo.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:24

    Topics: 4-Nitroquinoline-1-oxide; Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Male; Matrix Metalloproteinase 2; Methotrexate; Mouth Neoplasms; Nanoparticles; Quinolones; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2014
Comparison of injectable doxorubicin & its nanodrug complex chemotherapy for the treatment of 4-nitroquinoline-1-oxide induced oral squamous cell carcinoma in rats.
    The Indian journal of medical research, 2017, Volume: 145, Issue:1

    Topics: 4-Nitroquinoline-1-oxide; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Doxorubicin; Drug Delivery Systems; Head and Neck Neoplasms; Humans; Methotrexate; Nanoparticles; Rats; Squamous Cell Carcinoma of Head and Neck

2017